Although much more research is required, the targeting of specific binding motifs involved in CaM regulation of these key enzymes is presented as a novel and precise therapeutic approach for the prevention of Tau phosphorylation and aggregation in various tauopathies. This evidence concerns the gene MAPT and tauopathy.